secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonendo, Inc. (SONX)
CIK:        0001407973
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0000950170-24-111050
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonendo to acquire certain Biolase assets for $14M; files $59M patent claim
---------------------------------------------------------------------------

- Sonendo signs asset purchase agreement to buy dental laser assets of bankrupt Biolase for $14M cash plus liability assumption.
- Sonendo designated as stalking horse bidder; sale subject to Bankruptcy Court approval and higher competing bids.
- Break-up fee of $420K plus expense reimbursement payable if Sellers accept a competing bid.
- Sonendo subsidiary files $59M proof of claim in Biolase bankruptcy for alleged patent infringement.
- Transaction expected to close by Dec 31, 2024; no assurances of successful acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1407973/000095017024111050/0000950170-24-111050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1407973/000095017024111050/sonx-20240930.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-111050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer